Evidence map›Paper›PMID 37990503›Full record

ArticleCartilage2025

Integrin α10β1-Selected Mesenchymal Stem Cells Reduce Pain and Cartilage Degradation and Increase Immunomodulation in an Equine Osteoarthritis Model.

Camilla Andersen, Stine Jacobsen, Kristina Uvebrant, John F Griffin, Lucienne Angela Vonk, Marie Walters, Lise Charlotte Berg, Evy Lundgren-Åkerlund, Casper Lindegaard

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cartilage, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Equine MicroRNAs: Performance, Reproduction, and Disease.MicroRNA (Shariqah, United Arab Emirates) · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Camilla AndersenDepartment of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, Denmark.ORCID 0000-0002-6659-154X
Stine JacobsenDepartment of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, Denmark.
Kristina UvebrantXintela AB, Lund, Sweden.
John F GriffinDepartment of Large Animal Clinical Sciences, Texas A&M University, College Station, TX, USA.
Lucienne Angela VonkXintela AB, Lund, Sweden.
Marie WaltersDepartment of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, Denmark.
Lise Charlotte BergDepartment of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, Denmark.
Evy Lundgren-ÅkerlundXintela AB, Lund, Sweden.
Casper LindegaardDepartment of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, Denmark.
University of Copenhagen · DKTexas College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ObjectiveIntegrin α10β1-selected mesenchymal stem cells (integrin α10-MSCs) have previously shown potential in treating cartilage damage and osteoarthritis (OA)

Indexed as

Cartilage, ArticularImmunomodulationMesenchymal Stem CellsMesenchymal Stem Cell TransplantationOsteoarthritisPainAnimalsDisease Models, AnimalFemaleHorsesInjections, Intra-ArticularLameness, AnimalMaleSynovial Fluidarticular cartilageimmunomodulationmesenchymal stem cellsosteoarthritis disease modificationpain

Identifiers

PMID37990503
PMCPMC12086101
OpenAlexW4388908836

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.